thromboxanes has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, D; Crawford, A; Martin, TJ | 1 |
| Gross, S; Mehta, P; Ostrowski, N | 1 |
2 other study(ies) available for thromboxanes and Osteogenic Sarcoma
| Article | Year |
|---|---|
Rat osteogenic sarcoma cells: comparison of the effects of prostaglandins E1, E2, I2 (prostacyclin), 6-keto F1alpha and thromboxane B2 on cyclic AMP production and adenylate cyclase activity.
Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Epoprostenol; Osteosarcoma; Prostaglandins; Prostaglandins E; Rats; Sarcoma, Experimental; Thromboxane B2; Thromboxanes | 1978 |
Plasma concentrations of thromboxane and prostacyclin metabolites in patients with bone tumors.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Bone Neoplasms; Female; Humans; Male; Osteosarcoma; Reference Values; Sarcoma, Ewing; Sarcoma, Synovial; Thromboxane B2; Thromboxanes | 1985 |